PMDA drug package insert
マスチゲン錠8〜14歳用
PMDA OTC drug · 日本臓器製薬（株） · package insert Dec 14, 2020
Key facts
| Brand names | マスチゲン錠8〜14歳用 |
|---|---|
| Companies | 製造販売元／日本臓器製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 貧血用薬 |
| Package insert date | Dec 14, 2020 |
| PMDA document key | 530288_J1601000218 |
| PMDA company code | 530288 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: